Historique
Clinical Pharmacology and Therapeutics, Vol.101, n°2. Designer Drugs 2.0 - February 2017
| Titre : | Clinical Pharmacology and Therapeutics, Vol.101, n°2. Designer Drugs 2.0 - February 2017 |
| Type de document : | Bulletin |
| Paru le : | 01/02/2017 |
Dépouillements
Ajouter le résultat à votre sélection
P. GRIFFITHS ;
J. MOUNTENEY
|
2017
Dans Clinical Pharmacology and Therapeutics (Vol.101, n°2, February 2017) Article : Périodique
Dans Clinical Pharmacology and Therapeutics (Vol.101, n°2, February 2017) Article : Périodique
The internet facilitates rapid and covert communication, knowledge transfer, and has the potential to disrupt and transform drug market models and associated consumption patterns. Innovation and new trends diffuse rapidly through this medium and[...]
R. LE BOISSELIER ;
J. ALEXANDRE ;
V. LELONG-BOULOUARD ;
D. DEBRUYNE
|
2017
Dans Clinical Pharmacology and Therapeutics (Vol.101, n°2, February 2017) Article : Périodique
Dans Clinical Pharmacology and Therapeutics (Vol.101, n°2, February 2017) Article : Périodique
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state-of-the-art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the[...]